James Keegan

Jimmy is a Clinical Trial Specialist at Alnylam Pharmaceuticals. In his three and a half years in Clinical Operations, he has worked on studies from Phase 1 through 4, participated in multiple regulatory inspections, and helped to implement new projects and systems across clinical operations. He holds a Bachelor’s degree in Healthcare management and is currently pursuing a Master of Public Health degree at Boston University.